Deals
Immune Pharmaceuticals Raises $5M at 40% Premium From Discover Growth Fund
|
Immune Pharmaceuticals (NASDAQ CM:IMNP) announced that it has raised $4,778,500 in a Convertible Preferred Stock transaction.
Growth Capitalist (https://growthcapitalist.com/category/deals/page/153/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
Immune Pharmaceuticals (NASDAQ CM:IMNP) announced that it has raised $4,778,500 in a Convertible Preferred Stock transaction.
Genocea Biosciences (NASDAQ GM:GNCA) announced that it has raised $50,050,000 in a CMPO/Overnight transaction.
Elite Data Services (OTC BB:DEAC) announced that it has secured up to $5,000,000 in a Structured Equity Line transaction with Southridge Partners II, LP.
Unilife Corporation (NASDAQ GM:UNIS) announced that it has secured up to $45,000,000 in a Structured Equity Line transaction.